Patents by Inventor Luis Gabriel Gimenez-Lirola

Luis Gabriel Gimenez-Lirola has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Porcine Circovirus Type 3 (PCV3) vaccines, and production and uses thereof
    Patent number: 11896659
    Abstract: The present invention relates to the use of an immunogenic composition that comprises a porcine circovirus type 3 (PCV3) antigen for treatment of several clinical manifestations (diseases). Preferably, the clinical manifestations are associated with a PCV3 infection.
    Type: Grant
    Filed: November 23, 2022
    Date of Patent: February 13, 2024
    Inventors: Arun Iyer, Luis Alejandro Hernandez, Abby Patterson, Bailey Arruda, Luis Gabriel Gimenez-Lirola, Dave Michael Anstrom, Eric M. Vaughn, Pablo E Pineyro Pineiro, Troy James Kaiser, Joseph Ralph Hermann
  • Chimeric polyprotein for vaccines and diagnostics
    Patent number: 11891417
    Abstract: The present invention is directed to novel polynucleotides, polypeptides, and polyproteins of Mycoplasma surface proteins, all of which are useful in detecting infection and for the preparation of vaccines for treating and preventing diseases in swine and other animals. Vaccines provided according to the practice of the invention are effective against Mycoplasma infections. Detection and therapeutic polyclonal and monoclonal antibodies are also a feature of the present invention. Assays, kits, systems, and nanoparticle encapsulated compositions related to the polynucleotides, polypeptides, polyproteins, antibodies or fragments, derivatives, and variants thereof are also disclosed.
    Type: Grant
    Filed: November 3, 2022
    Date of Patent: February 6, 2024
    Assignee: Iowa State University Research Foundation, Inc.
    Inventors: Luis Gabriel Gimenez-Lirola, Bailey Arruda
  • Porcine Circovirus Type 3 (PCV3) Vaccines, and Production and Uses Thereof
    Publication number: 20230302113
    Abstract: The present invention relates to the use of an immunogenic composition that comprises a porcine circovirus type 3 (PCV3) antigen for treatment of several clinical manifestations (diseases). Preferably, the clinical manifestations are associated with a PCV3 infection.
    Type: Application
    Filed: November 23, 2022
    Publication date: September 28, 2023
    Inventors: Arun IYER, Luis Alejandro Hernandez, Abby Patterson, Bailey Arruda, Luis Gabriel Gimenez-Lirola, Dave Michael Anstrom, Eric M. Vaughn, Pablo E Pineyro Pineiro, Troy James Kaiser, Joseph Ralph Hermann
  • Porcine Circovirus Type 3 (PCV3) vaccines, and production and uses thereof
    Patent number: 11701419
    Abstract: The present invention relates to the use of an immunogenic composition that comprises a porcine circovirus type 3 (PCV3) antigen for treatment of several clinical manifestations (diseases). Preferably, the clinical manifestations are associated with a PCV3 infection.
    Type: Grant
    Filed: April 6, 2020
    Date of Patent: July 18, 2023
    Inventors: Arun Iyer, Luis Alejandro Hernandez, Abby Patterson, Bailey Arruda, Luis Gabriel Gimenez-Lirola, Dave Michael Anstrom, Eric M. Vaughn, Pablo E. Pineyro Pineiro, Troy James Kaiser, Joseph Ralph Hermann
  • CHIMERIC M. HYORHINIS POLYPROTEIN FOR VACCINES AND DIAGNOSTICS
    Publication number: 20230174594
    Abstract: The present invention is directed to novel polynucleotides, polypeptides, and polyproteins of Mycoplasma surface proteins, all of which are useful in detecting infection and for the preparation of vaccines for treating and preventing diseases in swine and other animals. Vaccines provided according to the practice of the invention are effective against Mycoplasma infections. Detection and therapeutic polyclonal and monoclonal antibodies are also a feature of the present invention. Assays, kits, systems, and nanoparticle encapsulated compositions related to the polynucleotides, polypeptides, polyproteins, antibodies or fragments, derivatives, and variants thereof are also disclosed.
    Type: Application
    Filed: November 3, 2022
    Publication date: June 8, 2023
    Inventors: Luis Gabriel Gimenez-Lirola, Bailey Arruda
  • Chimeric M. hyorhinis polyprotein for vaccines and diagnostics
    Patent number: 11524982
    Abstract: The present invention is directed to novel polynucleotides, polypeptides, and polyproteins of Mycoplasma surface proteins, all of which are useful in detecting infection and for the preparation of vaccines for treating and preventing diseases in swine and other animals. Vaccines provided according to the practice of the invention are effective against Mycoplasma infections. Detection and therapeutic polyclonal and monoclonal antibodies are also a feature of the present invention. Assays, kits, systems, and nanoparticle encapsulated compositions related to the polynucleotides, polypeptides, polyproteins, antibodies or fragments, derivatives, and variants thereof are also disclosed.
    Type: Grant
    Filed: January 28, 2020
    Date of Patent: December 13, 2022
    Assignee: Iowa State University Research Foundation, Inc.
    Inventors: Luis Gabriel Gimenez-Lirola, Bailey Arruda
  • Porcine Circovirus Type 3 (PCV3) Vaccines, and Production and Uses Thereof
    Publication number: 20210128712
    Abstract: The present invention relates to the use of an immunogenic composition that comprises a porcine circovirus type 3 (PCV3) antigen for treatment of several clinical manifestations (diseases). Preferably, the clinical manifestations are associated with a PCV3 infection.
    Type: Application
    Filed: April 6, 2020
    Publication date: May 6, 2021
    Inventors: Arun IYER, Luis Alejandro Hernandez, Abby Patterson, Bailey Arruda, Luis Gabriel Gimenez-Lirola, Dave Michael Anstrom, Eric M. Vaughn
  • CHIMERIC M. HYORHINIS POLYPROTEIN FOR VACCINES AND DIAGNOSTICS
    Publication number: 20200239526
    Abstract: The present invention is directed to novel polynucleotides, polypeptides, and polyproteins of Mycoplasma surface proteins, all of which are useful in detecting infection and for the preparation of vaccines for treating and preventing diseases in swine and other animals. Vaccines provided according to the practice of the invention are effective against Mycoplasma infections. Detection and therapeutic polyclonal and monoclonal antibodies are also a feature of the present invention. Assays, kits, systems, and nanoparticle encapsulated compositions related to the polynucleotides, polypeptides, polyproteins, antibodies or fragments, derivatives, and variants thereof are also disclosed.
    Type: Application
    Filed: January 28, 2020
    Publication date: July 30, 2020
    Inventors: Luis Gabriel Gimenez-Lirola, Bailey Arruda